Search - tctmd.com

Displaying 141 - 149 of 149

Sort: Relevancy | Date

News Daily News

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

Todd Neale

December 05, 2016

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News ESC 2016

New ESC A-fib Guidelines Call for Integrated Care for All Patients

Todd Neale

August 27, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados

Michael O'Riordan

March 31, 2016

News Daily News

AHA 发表声明警告称可穿戴除颤仪的有效性数据尚不充分

Michael O'Riordan

March 31, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

Advertisement

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

New ESC A-fib Guidelines Call for Integrated Care for All Patients

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados

AHA 发表声明警告称可穿戴除颤仪的有效性数据尚不充分

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content